Friday, 22 May 2020

Mynvax, IISc-incubated startup looks at Covid-19 vaccine in 18 months

Mynvax, which is backed by the Bill and Mellinda Gates foundation, has developed several candidate immunogens and completed initial animal trials.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)